Cargando…
A double masked randomised 4-week, placebo-controlled study in the USA, Thailand and Taiwan to compare the efficacy of oral valganciclovir and topical 2% ganciclovir in the treatment of cytomegalovirus anterior uveitis: study protocol
INTRODUCTION: Cytomegalovirus (CMV) anterior uveitis is a recognised cause of anterior uveitis in immunocompetent patients and is preventable cause of vision loss. Ocular sequelae include corneal endothelial damage which can cause corneal oedema and failure, as well as glaucoma. Recurrences of infla...
Autores principales: | Takhar, Jaskirat S, Joye, Ashlin S, Somkijrungroj, Thanapong, Laovirojjanakul, Wipada, Lin, Chang-Ping, Lietman, Thomas M, Porco, Travis C, Keenan, Jeremy D, Gebreegziabher, Elisabeth A, Seitzman, Gerami D, Rose-Nussbaumer, Jennifer, Doan, Thuy A, Acharya, Nisha R, Gonzales, John A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937053/ https://www.ncbi.nlm.nih.gov/pubmed/31862739 http://dx.doi.org/10.1136/bmjopen-2019-033175 |
Ejemplares similares
-
Acute Retinal Necrosis in an Immunocompetent Patient Treated With Intravitreal Ganciclovir
por: Nashawi, Mouhamed, et al.
Publicado: (2021) -
Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?
por: Mozaffar, Maryam, et al.
Publicado: (2018) -
Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship
por: Galar, Alicia, et al.
Publicado: (2021) -
Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir
por: Yang, Wenyu, et al.
Publicado: (2023) -
The patterns of uveitis and the factors affecting visual outcome from Chulalongkorn University Uveitis Cohort (CU(2)C): A 5-year longitudinal study protocol
por: Juhong, Jakkrit, et al.
Publicado: (2022)